Evidence Hub

Beyond Benefits of Q10: Mitochondrial Cocktail for Gulf War Illness

ClinicalTrials.gov · COMPLETED, 2023

15 participants

Abstract

The purpose of this study is to develop preliminary evidence, such as effect size and variance estimates, to guide successful conduct of a properly-powered clinical trial to assess the benefit of a mitochondrial cocktail (incorporating individualization of treatment) in Gulf War illness (GWI).

Conditions: Gulf War Syndrome, Persian Gulf Syndrome, Mitochondrial Disorders.

Primary outcome: Mean change in single item General Self-Rated Health Visual Analog Scale from baseline; Percent improved on Gulf War Illness Modified Lower Extremity Performance Score/timed chair rises; Number of symptoms (out of 20 on the UCSD Symptom Score Survey) showing more favorable change (trend or effect) on active treatment vs. placebo; Mean change of CoQ10 and Vitamin E levels, comparing active treatment to placebo.

Enrollment: 15 participants.

How strong is the evidence?

Evidence Hub reads this as a clinical trial, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence. Reported size: 15 participants or records.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free